• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭和射血分数降低患者健康状况保持的风险调整模型:CHAMP-HF 登记研究。

Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.

机构信息

Saint Luke's Mid America Heart Institute, Kansas City, MO (A.T.T., S.V.A., P.G.J., J.A.S.).

University of Missouri-Kansas City (A.T.T., S.V.A., P.G.J., J.A.S.).

出版信息

Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008072. doi: 10.1161/CIRCOUTCOMES.121.008072. Epub 2021 Oct 7.

DOI:10.1161/CIRCOUTCOMES.121.008072
PMID:34615366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8530961/
Abstract

BACKGROUND

Health status outcomes are increasingly being promoted as measures of health care quality, given their importance to patients. In heart failure (HF), an American College of Cardiology/American Heart Association Task Force proposed using the proportion of patients with preserved health status as a quality measure but not as a performance measure because risk adjustment methods were not available.

METHODS

We built risk adjustment models for alive with preserved health status and for preserved health status alone in a prospective registry of outpatients with HF with reduced ejection fraction across 146 US centers between December 2015 and October 2017. Preserved health status was defined as not having a ≥5-point decrease in the Kansas City Cardiomyopathy Questionnaire Overall Summary score at 1 year. Using only patient-level characteristics, hierarchical multivariable logistic regression models were developed for 1-year outcomes and validated using data from 1 to 2 years. We examined model calibration, discrimination, and variability in sites' unadjusted and adjusted rates.

RESULTS

Among 3932 participants (median age [interquartile range] 68 years [59-75], 29.7% female, 75.4% White), 2703 (68.7%) were alive with preserved health status, 902 (22.9%) were alive without preserved health status, and 327 (8.3%) had died by 1 year. The final risk adjustment model for alive with preserved health status included baseline Kansas City Cardiomyopathy Questionnaire Overall Summary, age, race, employment status, annual income, body mass index, depression, atrial fibrillation, renal function, number of hospitalizations in the past 1 year, and duration of HF (optimism-corrected C statistic=0.62 with excellent calibration). Similar results were observed when deaths were ignored. The risk standardized proportion of patients alive with preserved health status across the 146 sites ranged from 62% at the 10th percentile to 75% at the 90th percentile. Variability across sites was modest and changed minimally with risk adjustment.

CONCLUSIONS

Through leveraging data from a large, outpatient, observational registry, we identified key factors to risk adjust sites' proportions of patients with preserved health status. These data lay the foundation for building quality measures that quantify treatment outcomes from patients' perspectives.

摘要

背景

鉴于健康状况对患者的重要性,健康状况结果越来越多地被作为医疗保健质量的衡量标准。在心力衰竭(HF)中,美国心脏病学会/美国心脏协会工作组提出使用具有健康状况保存的患者比例作为质量衡量标准,但不作为绩效衡量标准,因为尚无法进行风险调整。

方法

我们构建了存活且具有健康状况保存和仅具有健康状况保存的风险调整模型,模型数据来源于 2015 年 12 月至 2017 年 10 月期间,146 个美国中心的射血分数降低的心力衰竭门诊患者前瞻性登记处。健康状况保存定义为在 1 年内 Kansas City 心肌病问卷总评分无≥5 分的下降。仅使用患者水平的特征,采用分层多变量逻辑回归模型对 1 年的结果进行了开发,并使用 1 至 2 年的数据进行了验证。我们检查了模型校准、区分度以及各站点未调整和调整后比率的变异性。

结果

在 3932 名参与者(中位数年龄[四分位数范围]68 岁[59-75],29.7%为女性,75.4%为白人)中,2703 名(68.7%)存活且具有健康状况保存,902 名(22.9%)存活但无健康状况保存,327 名(8.3%)在 1 年内死亡。存活且具有健康状况保存的最终风险调整模型包括基线 Kansas City 心肌病问卷总评分、年龄、种族、就业状况、年收入、体重指数、抑郁、心房颤动、肾功能、过去 1 年的住院次数和心力衰竭持续时间(校正乐观偏差后的 C 统计量=0.62,具有极好的校准)。当忽略死亡时,也观察到类似的结果。在 146 个站点中,具有健康状况保存的患者存活比例的风险标准化比例范围从第 10 个百分位数的 62%到第 90 个百分位数的 75%。各站点间的变异性较小,且风险调整后变化不大。

结论

通过利用来自大型门诊观察性登记处的数据,我们确定了对各站点具有健康状况保存的患者比例进行风险调整的关键因素。这些数据为构建从患者角度量化治疗结果的质量衡量标准奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6df/8530961/9244904db790/nihms-1739984-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6df/8530961/5fa1547e69aa/nihms-1739984-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6df/8530961/9244904db790/nihms-1739984-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6df/8530961/5fa1547e69aa/nihms-1739984-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6df/8530961/9244904db790/nihms-1739984-f0002.jpg

相似文献

1
Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF Registry.心力衰竭和射血分数降低患者健康状况保持的风险调整模型:CHAMP-HF 登记研究。
Circ Cardiovasc Qual Outcomes. 2021 Oct;14(10):e008072. doi: 10.1161/CIRCOUTCOMES.121.008072. Epub 2021 Oct 7.
2
Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry.心力衰竭门诊患者不同医疗实践中的健康状况差异:来自CHAMP-HF(改变心力衰竭患者管理)注册研究的见解
Circ Cardiovasc Qual Outcomes. 2018 Apr;11(4):e004668. doi: 10.1161/CIRCOUTCOMES.118.004668.
3
Association of Changes in Heart Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF.心力衰竭治疗变化与患者健康状况的关联:来自 CHAMP-HF 的真实世界证据。
JACC Heart Fail. 2019 Jul;7(7):615-625. doi: 10.1016/j.jchf.2019.03.020. Epub 2019 Jun 5.
4
Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.堪萨斯城心肌病问卷在射血分数保留和降低的心衰患者中的可比表现。
Circ Heart Fail. 2013 Nov;6(6):1139-46. doi: 10.1161/CIRCHEARTFAILURE.113.000359. Epub 2013 Oct 15.
5
Comorbid Conditions and Health-Related Quality of Life in Ambulatory Heart Failure Patients: REVIVAL (Registry Evaluation of Vital Information for VADs in Ambulatory Life REVIVAL).门诊心力衰竭患者的合并症和健康相关生活质量:REVIVAL(在门诊生活中评估 VAD 重要信息的登记研究 REVIVAL)。
Circ Heart Fail. 2020 May;13(5):e006858. doi: 10.1161/CIRCHEARTFAILURE.119.006858. Epub 2020 May 18.
6
Association of Medication Adherence and Health Status in Heart Failure With Reduced Ejection Fraction: Insights From the CHAMP-HF Registry.射血分数降低的心力衰竭患者药物依从性与健康状况的相关性:来自 CHAMP-HF 登记研究的结果。
Circ Cardiovasc Qual Outcomes. 2024 Sep;17(9):e010211. doi: 10.1161/CIRCOUTCOMES.123.010211. Epub 2024 Jul 24.
7
Patient-Reported Versus Physician-Assessed Health Status in Heart Failure With Reduced and Preserved Ejection Fraction From ASIAN-HF Registry.亚洲心力衰竭注册研究中射血分数降低和保留的心力衰竭患者自我报告与医生评估的健康状况
Circ Cardiovasc Qual Outcomes. 2023 Jan;16(1):e009134. doi: 10.1161/CIRCOUTCOMES.122.009134. Epub 2022 Dec 9.
8
Comparison of New York Heart Association Class and Patient-Reported Outcomes for Heart Failure With Reduced Ejection Fraction.纽约心脏协会心功能分级与射血分数降低的心力衰竭患者报告结局的比较。
JAMA Cardiol. 2021 May 1;6(5):522-531. doi: 10.1001/jamacardio.2021.0372.
9
Change of Health-Related Quality of Life Over Time and Its Association With Patient Outcomes in Patients With Heart Failure.随着时间的推移,健康相关生活质量的变化及其与心力衰竭患者预后的关系。
J Am Heart Assoc. 2020 Sep;9(17):e017278. doi: 10.1161/JAHA.120.017278. Epub 2020 Aug 19.
10
Machine Learning Prediction of Mortality and Hospitalization in Heart Failure With Preserved Ejection Fraction.机器学习预测射血分数保留的心力衰竭患者的死亡率和住院率。
JACC Heart Fail. 2020 Jan;8(1):12-21. doi: 10.1016/j.jchf.2019.06.013. Epub 2019 Oct 9.

引用本文的文献

1
Effects of Tai Chi on health status in adults with chronic heart failure: A systematic review and meta-analysis.太极拳对慢性心力衰竭成年人健康状况的影响:一项系统评价和荟萃分析。
Front Cardiovasc Med. 2022 Sep 9;9:953657. doi: 10.3389/fcvm.2022.953657. eCollection 2022.

本文引用的文献

1
The Groundwater of Racial and Ethnic Disparities Research: A Statement From .种族和族裔差异研究中的地下水:.的声明
Circ Cardiovasc Qual Outcomes. 2021 Feb;14(2):e007868. doi: 10.1161/CIRCOUTCOMES.121.007868. Epub 2021 Feb 11.
2
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
3
Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review.
解读堪萨斯城心肌病问卷在临床试验和临床护理中的应用:美国心脏病学会最新综述
J Am Coll Cardiol. 2020 Nov 17;76(20):2379-2390. doi: 10.1016/j.jacc.2020.09.542.
4
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.2020年美国心脏病学会/美国心脏协会心力衰竭成人患者临床性能和质量指标:美国心脏病学会/美国心脏协会性能指标特别工作组报告
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e000099. doi: 10.1161/HCQ.0000000000000099. Epub 2020 Nov 2.
5
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.恩格列净治疗心力衰竭的心血管和肾脏结局。
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
6
Hidden in Plain Sight - Reconsidering the Use of Race Correction in Clinical Algorithms.隐匿于众目睽睽之下——重新审视临床算法中种族校正的应用
N Engl J Med. 2020 Aug 27;383(9):874-882. doi: 10.1056/NEJMms2004740. Epub 2020 Jun 17.
7
Contemporary Treatment Patterns and Clinical Outcomes of Comorbid Diabetes Mellitus and HFrEF: The CHAMP-HF Registry.合并糖尿病与射血分数降低心衰(HFrEF)患者的当代治疗模式与临床结局:CHAMP-HF 注册研究。
JACC Heart Fail. 2020 Jun;8(6):469-480. doi: 10.1016/j.jchf.2019.12.015. Epub 2020 May 6.
8
Temporal Trends in Racial Differences in 30-Day Readmission and Mortality Rates After Acute Myocardial Infarction Among Medicare Beneficiaries.在 Medicare 受益人群中,急性心肌梗死后 30 天再入院率和死亡率的种族差异的时间趋势。
JAMA Cardiol. 2020 Feb 1;5(2):136-145. doi: 10.1001/jamacardio.2019.4845.
9
International Consortium for Health Outcomes Measurement (ICHOM): Standardized Patient-Centered Outcomes Measurement Set for Heart Failure Patients.国际健康结果测量联合会(ICHOM):心力衰竭患者以患者为中心的标准化结局测量集。
JACC Heart Fail. 2020 Mar;8(3):212-222. doi: 10.1016/j.jchf.2019.09.007. Epub 2019 Dec 11.
10
Quality of life predicting long-term outcomes in cardiac resynchronization therapy patients.生活质量预测心脏再同步治疗患者的长期预后。
Europace. 2019 Dec 1;21(12):1865-1875. doi: 10.1093/europace/euz262.